Abstract:Multiple myeloma (MM) is an indolent B-cell disease characterized by clonal proliferation of malignant plasma cells. Multiple myeloma remains incurable despite new targeted drugs and development of drug resistance or intolerable toxicity emerges as a major problem. Therefore, design, identification, and validation of novel chemicals with therapeutic potential are clearly needed for MM treatment. Here, we explore polyphyllin I (PPI), a major active constituent extracted from Paris polyphyllin, its inhibitory effects and its mechanisms in MM cells in vitro. We found that PPI inhibited the proliferation of myeloma cells. The combination of PPI with dexamethasone, doxorubicin, arsenic trioxide, or bortezomib enhanced the inhibition of cell growth. As analyzed by flow cytometry, MM cells were arrested at G2/M phase and apoptotic cells increased in a time-dependent manner. Morphological changes of cells undergoing apoptosis were observed under light microscope. To explore the mechanism of apoptosis induced by PPI, we next examined whether the Wingless-Int (Wnt)/-catenin signaling pathway played a role in the PPI-induced growth inhibition in MM cells. The canonical Wnt signaling pathway is activated in MM cells through constitutively active -catenin, a messenger molecule relevant to growth, survival, and migration of MM cells. Western blotting was used to measure the protein levels of -catenin, and PPI treatment led to downregulating the expression of -catenin protein and was followed by inhibition of -catenin nuclear localization. As a result, -catenin downstream targets, such as cyclin D1 and survivin, were downregulated. To the best of our knowledge, this is the first report identifying anti-proliferative potency of PPI against myeloma cells. PPI blocks -catenin nuclear translocation and decreasing expression of the downstream targets of -catenin. Our results suggest that PPI is a novel inhibitor of -catenin activity with potential anti-myeloma efficacy.

Antitumor Effects, Cell Selectivity and Structure–activity Relationship of a Novel Antimicrobial Peptide Polybia-Mpi

A Novel Analog of Antimicrobial Peptide Polybia-MPI, with Thioamide Bond Substitution, Exhibits Increased Therapeutic Efficacy Against Cancer and Diminished Toxicity in Mice.

Novel mode of action of polybia-MPI, a novel antimicrobial peptide, in multi-drug resistant leukemic cells.

Membrane Active Antimicrobial Activity and Molecular Dynamics Study of a Novel Cationic Antimicrobial Peptide Polybia-Mpi, from the Venom of Polybia Paulista

Novel cytotoxity exhibition mode of polybia-CP, a novel antimicrobial peptide from the venom of the social wasp Polybia paulista.

Antimicrobial Activity and Stability of the D-amino Acid Substituted Derivatives of Antimicrobial Peptide Polybia-Mpi.

Membrane-active Action Mode of Polybia-Cp, a Novel Antimicrobial Peptide Isolated from the Venom of Polybia Paulista.

Design, Synthesis and Biological Evaluation of Novel Tripeptidyl Epoxyketone Derivatives Constructed from Β-Amino Acid As Proteasome Inhibitors.

The Effects of Incorporation of the Counterparts and Mimics of L-lysine on the Antimicrobial Activity, Hemolytic Activity, Cytotoxicity and Tryptic Stability of Antimicrobial Peptide Polybia-Mpii.

Dual antifungal properties of cationic antimicrobial peptides polybia-MPI: Membrane integrity disruption and inhibition of biofilm formation

Antifungal Effect And Action Mechanism Of Antimicrobial Peptide Polybia-Cp

Intramolecular Cyclization of the Antimicrobial Peptide Polybia-MPI with Triazole Stapling: Influence on Stability and Bioactivity

Synthesis and Biological Evaluation of Novel Peptides Based on Antimicrobial Peptides As Potential Agents with Antitumor and Multidrug Resistance-Reversing Activities

Synthesis and Biological Evaluation of Novel Aliphatic Acid-Conjugated Antimicrobial Peptides As Potential Agents with Anti-Tumor, Multidrug Resistance-Reversing Activity and Enhanced Stability

Design, synthesis and biological evaluation of novel peptides as potential agents with anti-tumor and multidrug resistance-reversing activities

Polyphyllin I Induces Cell Cycle Arrest and Apoptosis in Human Myeloma Cells Via Modulating Β‐catenin Signaling Pathway

Design, Synthesis and Biological Evaluation of Novel Non-peptide Boronic Acid Derivatives As Proteasome Inhibitors

Design of an acid-activated antimicrobial peptide for tumor therapy.

Membrane Perturbation Action Mode and Structure-Activity Relationships of Protonectin, a Novel Antimicrobial Peptide from the Venom of the Neotropical Social Wasp Agelaia Pallipes Pallipes.

Designed Antimicrobial and Antitumor Peptides with High Selectivity.

Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma